GlassScriptPhysician profile
Eric Spencer Weiss
NPI 1639581770
$28,168.34
in general payments reported to CMS, 2019-2025
26 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $79.73 · 2021: $527 · 2022: $975 · 2023: $3,350 · 2024: $4,708 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $3,072 · Honoraria: $1,200 · Long Term Medical Supply Or Device Loan: $326 · Travel and Lodging: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,180.00 |
| Food and Beverage | $3,071.89 |
| Honoraria | $1,200.00 |
| Long Term Medical Supply Or Device Loan | $325.80 |
| Travel and Lodging | $266.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $12,667.39 | 2025 | |
| Baxter Healthcare | $5,580.00 | 2023-2024 | Peri-Strips Dry, Tisseel, Seprafilm |
| Polynovo North America LLC | $3,644.19 | 2023-2025 | Novosorb Btm |
| Rti Surgical, INC | $1,200.00 | 2024 | |
| Integra Lifesciences Corporation | $997.04 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Durasorb Monofilament Mesh |
| Abbvie INC. | $737.53 | 2023-2025 | Alloderm |
| Sientra, INC. | $584.31 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $471.44 | 2024-2025 | |
| Tela Bio, INC. | $419.16 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kci USA, INC. | $215.21 | 2021-2022 | |
| Avita Medical Americas, LLC | $174.48 | 2024-2025 | Cohealyx, Permeaderm, Recell |
| Smith+Nephew, INC. | $158.50 | 2023-2025 | Pico 14, Renasys Touch, Grafix Pl |
| W. L. Gore & Associates, INC. | $157.96 | 2019 | |
| Ethicon US, LLC | $147.38 | 2019 | |
| Kerecis Limited | $147.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $133.25 | 2024-2025 | Prevena, Prevena Restor Bellaform, V.A.C. Veraflo Cleanse Choice |
| Allergan, INC. | $125.00 | 2019 | |
| Boston Scientific Corporation | $112.20 | 2019 | |
| Misonix INC | $91.12 | 2020-2021 | |
| Axogen | $82.90 | 2022 | |
| Aroa Biosurgery Incorporated | $74.43 | 2025 | |
| Mentor Worldwide LLC | $74.16 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Motiva USA, LLC | $63.75 | 2025 | |
| Depuy Synthes Sales INC. | $59.46 | 2021 | |
| Stryker Corporation | $31.31 | 2025 | Osteoset |
| Acumed LLC | $18.80 | 2025 | Osteomed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.